CN1103578A - 生发剂及其制备 - Google Patents

生发剂及其制备 Download PDF

Info

Publication number: CN1103578A
Authority: CN; China
Prior art keywords: hair growth; chemical compound; growth promoter; carrier; hair
Prior art date: 1993-04-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN94105397A

Other languages

English (en)

Chinese (zh)

Inventor

阿贺创

涉谷孝

杉本利行

三宅俊雄

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hayashibara Seibutsu Kagaku Kenkyujo KK

Original Assignee

Hayashibara Seibutsu Kagaku Kenkyujo KK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-28

Filing date

1994-04-28

Publication date

1995-06-14

1994-04-28 Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK

1995-06-14 Publication of CN1103578A publication Critical patent/CN1103578A/zh

Status Pending legal-status Critical Current

Links

210000004209 hair Anatomy 0.000 title abstract description 19
238000002360 preparation method Methods 0.000 title description 18
150000001875 compounds Chemical class 0.000 claims abstract description 78
150000003839 salts Chemical class 0.000 claims abstract description 19
239000004615 ingredient Substances 0.000 claims abstract description 13
230000003779 hair growth Effects 0.000 claims description 66
239000007952 growth promoter Substances 0.000 claims description 41
BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 claims description 16
238000000034 method Methods 0.000 claims description 11
239000000203 mixture Substances 0.000 claims description 9
ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 7
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims description 5
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 4
229920002554 vinyl polymer Polymers 0.000 claims description 4
239000013078 crystal Substances 0.000 claims description 3
AZUVPZMWUDNKRA-UHFFFAOYSA-N O1C=NC=C1.[I] Chemical compound O1C=NC=C1.[I] AZUVPZMWUDNKRA-UHFFFAOYSA-N 0.000 claims 2
239000003581 cosmetic carrier Substances 0.000 claims 2
239000003937 drug carrier Substances 0.000 claims 2
JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
201000004384 Alopecia Diseases 0.000 abstract description 26
231100000360 alopecia Toxicity 0.000 abstract description 23
230000000694 effects Effects 0.000 abstract description 17
238000011069 regeneration method Methods 0.000 abstract description 16
230000002265 prevention Effects 0.000 abstract description 2
230000008929 regeneration Effects 0.000 abstract description 2
KABCFARPAMSXCC-JXMROGBWSA-N (e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-enoic acid Chemical compound CC(C)=CCC1=CC(\C=C\C(O)=O)=CC(CC=C(C)C)=C1O KABCFARPAMSXCC-JXMROGBWSA-N 0.000 abstract 1
BJIVLGIZOMJQRT-UHFFFAOYSA-N 3-[3-(3-methylbut-2-enyl)-4-(3-phenylpropanoyloxy)phenyl]prop-2-enoic acid Chemical compound CC(C)=CCC1=CC(C=CC(O)=O)=CC=C1OC(=O)CCC1=CC=CC=C1 BJIVLGIZOMJQRT-UHFFFAOYSA-N 0.000 abstract 1
KABCFARPAMSXCC-UHFFFAOYSA-N artepillin C Natural products CC(C)=CCC1=CC(C=CC(O)=O)=CC(CC=C(C)C)=C1O KABCFARPAMSXCC-UHFFFAOYSA-N 0.000 abstract 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
230000003660 hair regeneration Effects 0.000 description 15
239000000047 product Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
210000003128 head Anatomy 0.000 description 12
-1 myristic acid, 2-octyl group dodecyl ester Chemical class 0.000 description 12
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
239000000243 solution Substances 0.000 description 11
239000000126 substance Substances 0.000 description 11
239000003795 chemical substances by application Substances 0.000 description 10
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
239000008213 purified water Substances 0.000 description 9
241000241413 Propolis Species 0.000 description 7
230000035617 depilation Effects 0.000 description 7
229940069949 propolis Drugs 0.000 description 7
208000001840 Dandruff Diseases 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
238000000862 absorption spectrum Methods 0.000 description 6
230000003110 anti-inflammatory effect Effects 0.000 description 6
239000002904 solvent Substances 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
238000004566 IR spectroscopy Methods 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
238000005481 NMR spectroscopy Methods 0.000 description 5
229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
208000003251 Pruritus Diseases 0.000 description 5
239000002537 cosmetic Substances 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
230000002421 anti-septic effect Effects 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
238000004440 column chromatography Methods 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
208000004396 mastitis Diseases 0.000 description 4
239000002674 ointment Substances 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
235000013599 spices Nutrition 0.000 description 4
230000001954 sterilising effect Effects 0.000 description 4
238000004659 sterilization and disinfection Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000628997 Flos Species 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
208000004631 alopecia areata Diseases 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000002453 shampoo Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
230000001256 tonic effect Effects 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
241000208838 Asteraceae Species 0.000 description 2
241000195940 Bryophyta Species 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
239000002211 L-ascorbic acid Substances 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000003086 colorant Substances 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000010828 elution Methods 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
238000000605 extraction Methods 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
208000024963 hair loss Diseases 0.000 description 2
230000003676 hair loss Effects 0.000 description 2
239000003906 humectant Substances 0.000 description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229940057995 liquid paraffin Drugs 0.000 description 2
239000006210 lotion Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
235000011929 mousse Nutrition 0.000 description 2
229940055577 oleyl alcohol Drugs 0.000 description 2
XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
239000012071 phase Substances 0.000 description 2
230000002028 premature Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
230000000472 traumatic effect Effects 0.000 description 2
210000002268 wool Anatomy 0.000 description 2
NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
241000726096 Aratinga Species 0.000 description 1
235000008658 Artemisia capillaris Nutrition 0.000 description 1
241000092668 Artemisia capillaris Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
241001191009 Gymnomyza Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
CWNSVVHTTQBGQB-UHFFFAOYSA-N N,N-Diethyldodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CC)CC CWNSVVHTTQBGQB-UHFFFAOYSA-N 0.000 description 1
241000772415 Neovison vison Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000287219 Serinus canaria Species 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
239000004902 Softening Agent Substances 0.000 description 1
240000004460 Tanacetum coccineum Species 0.000 description 1
241001416177 Vicugna pacos Species 0.000 description 1
241000282487 Vulpes Species 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
210000000077 angora Anatomy 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000002951 depilatory effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000002651 drug therapy Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000003810 ethyl acetate extraction Methods 0.000 description 1
210000004709 eyebrow Anatomy 0.000 description 1
210000003746 feather Anatomy 0.000 description 1
235000008384 feverfew Nutrition 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
230000003648 hair appearance Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
210000000088 lip Anatomy 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000012046 mixed solvent Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
150000002916 oxazoles Chemical class 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000007670 refining Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
239000012488 sample solution Substances 0.000 description 1
239000011265 semifinished product Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
238000010898 silica gel chromatography Methods 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical group [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
229940084106 spermaceti Drugs 0.000 description 1
239000012177 spermaceti Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000002541 vasodepressive effect Effects 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000003021 water soluble solvent Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Botany (AREA)
Microbiology (AREA)
Mycology (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CN94105397A 1993-04-28 1994-04-28 生发剂及其制备 Pending CN1103578A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP123223/93		1993-04-28
JP12322393A JP3409165B2 (ja)	1993-04-28	1993-04-28	養毛剤とその製造方法

Publications (1)

Publication Number	Publication Date
CN1103578A true CN1103578A (zh)	1995-06-14

Family

ID=14855254

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN94105397A Pending CN1103578A (zh)	1993-04-28	1994-04-28	生发剂及其制备

Country Status (8)

Country	Link
US (1)	US5556866A (2)
EP (1)	EP0622068B1 (2)
JP (1)	JP3409165B2 (2)
KR (1)	KR100275657B1 (2)
CN (1)	CN1103578A (2)
BR (1)	BR9401642A (2)
DE (1)	DE69411981T2 (2)
TW (1)	TW279798B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108014328A (zh) *	2017-12-19	2018-05-11	吴广印	一种预防脱发、促进生发物质的配方及其制备方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5922324A (en) *	1995-01-31	1999-07-13	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Propolis extract with improved water-solubility
US5710179A (en) *	1995-04-05	1998-01-20	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Antitumor agent
JP4135816B2 (ja) *	1995-11-24	2008-08-20	株式会社林原生物化学研究所	水溶性を向上させたプロポリス抽出物
JPH09328425A (ja) *	1996-04-12	1997-12-22	Hayashibara Biochem Lab Inc	アポトーシス調節剤
JP2009001569A (ja) *	1996-04-12	2009-01-08	Hayashibara Biochem Lab Inc	アポトーシス調節剤
JP4634552B2 (ja) *	1999-03-26	2011-02-16	株式会社皇漢薬品研究所	不溶性分を除去した精製プロポリス抽出液の製造方法及び不溶成分を除去した精製プロポリス抽出液
US20060263452A1 (en) *	2005-05-17	2006-11-23	Alwyn Dowell	Topical composition containing essential oils
ES2614931T3 (es) *	2006-08-04	2017-06-02	Beth Israel Deaconess Medical Center	Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
JP5210527B2 (ja) *	2007-02-15	2013-06-12	株式会社感光社	防腐殺菌保湿剤及び皮膚・毛髪外用組成物
CA2758071C (en)	2009-04-06	2018-01-09	Agios Pharmaceuticals, Inc.	Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
ES2619557T3 (es)	2009-05-04	2017-06-26	Agios Pharmaceuticals, Inc.	Activadores de PKM2 para uso en el tratamiento del cáncer
EP2448581B1 (en)	2009-06-29	2016-12-07	Agios Pharmaceuticals, Inc.	Therapeutic compositions and related methods of use
SG10201403696UA (en)	2009-06-29	2014-10-30	Agios Pharmaceuticals Inc	Therapeutic compounds and compositions
CA2821975A1 (en)	2010-12-17	2012-06-21	Shunqi Yan	N-(4-(azetidine-1-carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 pkm2 modulators
WO2012088314A1 (en)	2010-12-21	2012-06-28	Agios Pharmaceuticals, Inc.	Bicyclic pkm2 activators
TWI549947B (zh)	2010-12-29	2016-09-21	阿吉歐斯製藥公司	治療化合物及組成物
DE102011050030B4 (de)	2011-05-02	2013-03-28	Scanlab Ag	Positionsdetektor und Lichtablenkvorrichtung mit Positionsdetektor
JP6272754B2 (ja)	2011-05-03	2018-01-31	アジオスファーマシューティカルズ，インコーポレイテッド	ピルビン酸キナーゼ活性化剤の使用方法
RS64777B1 (sr)	2015-06-11	2023-11-30	Agios Pharmaceuticals Inc	Postupci upotrebe aktivatora piruvat kinaze

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59118736A (ja) *	1982-12-27	1984-07-09	Res Inst For Prod Dev	３−〔４−ヒドロキシ−３−（３−ヒドロキシメチル−２−ブテニル）−５−（３−メチル−２−ブテニル）〕フエニル−２（ｚ）−プロペニツク酸
JPS60163841A (ja) *	1984-02-06	1985-08-26	Res Inst For Prod Dev	３−（４−ヒドロキシフエニル）−２（ｅ）−プロペニツク酸
JP2926432B2 (ja) *	1990-06-11	1999-07-28	株式会社林原生物化学研究所	養毛剤
TW224052B (2) *	1991-08-27	1994-05-21	Hayasibara Biology & Chemicals Res

1993
- 1993-04-28 JP JP12322393A patent/JP3409165B2/ja not_active Expired - Lifetime
1994
- 1994-04-26 DE DE69411981T patent/DE69411981T2/de not_active Expired - Fee Related
- 1994-04-26 EP EP94303008A patent/EP0622068B1/en not_active Expired - Lifetime
- 1994-04-27 TW TW083103797A patent/TW279798B/zh active
- 1994-04-27 KR KR1019940008974A patent/KR100275657B1/ko not_active Expired - Fee Related
- 1994-04-28 BR BR9401642A patent/BR9401642A/pt not_active Application Discontinuation
- 1994-04-28 CN CN94105397A patent/CN1103578A/zh active Pending
- 1994-04-28 US US08/234,384 patent/US5556866A/en not_active Expired - Fee Related

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108014328A (zh) *	2017-12-19	2018-05-11	吴广印	一种预防脱发、促进生发物质的配方及其制备方法

Also Published As

Publication number	Publication date
EP0622068A2 (en)	1994-11-02
DE69411981D1 (de)	1998-09-03
EP0622068A3 (en)	1994-12-07
EP0622068B1 (en)	1998-07-29
US5556866A (en)	1996-09-17
JPH06312918A (ja)	1994-11-08
TW279798B (2)	1996-07-01
BR9401642A (pt)	1994-11-01
JP3409165B2 (ja)	2003-05-26
KR100275657B1 (ko)	2000-12-15
DE69411981T2 (de)	1999-01-21

Legal Events

Date	Code	Title
1995-06-14	C06	Publication
1995-06-14	PB01	Publication
1996-07-31	C10	Entry into substantive examination
1996-07-31	SE01	Entry into force of request for substantive examination
2000-08-09	C01	Deemed withdrawal of patent application (patent law 1993)
2000-08-09	WD01	Invention patent application deemed withdrawn after publication

Publication	Publication Date	Title
CN100337685C (zh)	2007-09-19	减少毛发生长、毛囊及毛干尺寸与毛发色素沉着
JP3409165B2 (ja)	2003-05-26	養毛剤とその製造方法
CN101068525A (zh)	2007-11-07	用于改善皮肤情况和外观的组合物及其应用方法
JP2002520275A (ja)	2002-07-09	皮膚病の治療
JP6145505B2 (ja)	2017-06-14	光照射を用いた感光剤−ペプチドを有効成分として含む発毛改善または促進用組成物及びそれを用いた方法
KR20170121468A (ko)	2017-11-02	감귤류 과피 추출물을 포함하는 피부 조직 재생용 조성물
CN1194967A (zh)	1998-10-07	具有改进水溶性的蜂胶提取物
JP2012219027A (ja)	2012-11-12	育毛剤
JP5403582B2 (ja)	2014-01-29	Ａｔｐ産生促進剤
KR102513248B1 (ko)	2023-03-24	펄스 전기장이 처리된 미역귀 추출물을 포함하는 조성물
EP0792646B1 (fr)	2002-05-22	Compositions cosmétiques ou dermopharmaceutiques contenant un extrait de Solanum lycocarpum
JP7453705B2 (ja)	2024-03-21	エキソソーム及びその調製プロセス及びその使用
JP4362524B2 (ja)	2009-11-11	Ｂｃｌ−２蛋白発現剤、アポトーシス抑制剤および表皮細胞の紫外線ｄｎａ障害防止剤
JP7053169B2 (ja)	2022-04-12	プロコラーゲンプロセッシング促進剤
JP2022160101A (ja)	2022-10-19	乳由来エクソソーム様ベシクル含有皮膚外用剤、コラーゲン産生促進剤およびエラスチン産生促進剤
JP7863392B1 (ja)	2026-05-21	育毛用組成物
JP2988633B2 (ja)	1999-12-13	発毛・育毛剤
JP7617656B2 (ja)	2025-01-20	特定成分含有組成物
CN102036674B (zh)	2013-07-31	Bcl-2蛋白表达剂、细胞凋亡抑制剂和表皮细胞的紫外线dna损伤防止剂
JP2020033302A (ja)	2020-03-05	柿葉抽出物を含む美白剤
KR101910595B1 (ko)	2018-10-22	터티오펜 유도체를 함유하는 탈모치료 및 발모촉진용 조성물
JP6291466B2 (ja)	2018-03-14	皮膚バリア機能改善剤、細胞間接着構造の形成促進剤、タイトジャンクション形成促進剤、ＴＲＰＶ４活性化剤、細胞内Ｃａ濃度上昇亢進剤及び皮脂産生促進剤
JP2018177702A (ja)	2018-11-15	ノリウツギ抽出物を有効成分とする皮膚老化防止剤及びそれを含有する皮膚外用剤
JPH03123720A (ja)	1991-05-27	養毛化粧料
CN118526436A (zh)	2024-08-23	一种具有防脱发及保湿修护作用的中药氨基酸洗发水及其制备方法

CN1103578A - 生发剂及其制备 - Google Patents

Info

Links

Images

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=14855254

Family Applications (1)

Country Status (8)

Cited By (1)

Families Citing this family (19)

Family Cites Families (4)

Cited By (1)

Also Published As

Similar Documents

Legal Events